AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32128957 — intervention group
Group type: EXPERIMENTAL
Intervention: Efpeglenatide overall
Number of subjects: 209
Study 32128957 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 209
Study 36201889 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleeping Sound intervention
Number of subjects: 123
Study 34224858 — intervention group
Group type: EXPERIMENTAL
Intervention: Mastiha
Number of subjects: 0
Study 34224858 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32886918 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventricular lavage/irrigation
Number of subjects: 33
Study 32886918 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (external ventricular drain with antibiotics)
Number of subjects: 33
Study 32915670 — intervention group
Group type: EXPERIMENTAL
Intervention: Writing for Recovery (WfR) intervention, six sessions
Number of subjects: 54
Study 32915670 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 54
Study 35352014 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice (providing 6.4 mmol NO3)
Number of subjects: 25
Study 35352014 — intervention group
Group type: COMPARATOR
Intervention: NO3-depleted beetroot juice (control)
Number of subjects: 25
Study 32991606 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelubiprofen CR 90 mg
Number of subjects: 191
Study 32991606 — intervention group
Group type: COMPARATOR
Intervention: Aceclofenac 200 mg
Number of subjects: 191
Study 35743685 — intervention group
Group type: EXPERIMENTAL
Intervention: Chitosan conduit
Number of subjects: 47
Study 35743685 — intervention group
Group type: COMPARATOR
Intervention: Autologous nerve graft
Number of subjects: 47
Study 32115753 — intervention group
Group type: EXPERIMENTAL
Intervention: RAI oral/dental items assessment
Number of subjects: 44
Study 32115753 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication processes for RAI assessments
Number of subjects: 44
Study 32115753 — intervention group
Group type: EXPERIMENTAL
Intervention: Integration of care aides in assessment processes
Number of subjects: 44
Study 33589759 — intervention group
Group type: EXPERIMENTAL
Intervention: Validated home blood pressure monitors (HBPMs)
Number of subjects: 21104
Study 33589759 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-validated home blood pressure monitors (HBPMs)
Number of subjects: 21104
Study 33589759 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper arm HBPMs
Number of subjects: 21104
Study 33589759 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrist HBPMs
Number of subjects: 21104
Study 33589759 — intervention group
Group type: EXPERIMENTAL
Intervention: Validated HBPMs
Number of subjects: 21104
Study 34438356 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive and behavioural mediators
Number of subjects: 640
Study 34438356 — intervention group
Group type: COMPARATOR
Intervention: Physical functioning and fatigue outcomes
Number of subjects: 640
Study 35276789 — intervention group
Group type: EXPERIMENTAL
Intervention: Low salt intervention
Number of subjects: 74
Study 35276789 — intervention group
Group type: EXPERIMENTAL
Intervention: High-nitrate vegetable intervention
Number of subjects: 74
Study 35276789 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined high-nitrate vegetable and low salt intervention
Number of subjects: 74
Study 35276789 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 74
Study 35961692 — intervention group
Group type: COMPARATOR
Intervention: Aspirin and clopidogrel (AC)
Number of subjects: 0
Study 35961692 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin and ticagrelor (AT)
Number of subjects: 0
Study 35961692 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin and prasugrel (AP)
Number of subjects: 0
Study 32058247 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulatory assessment of attentional bias (AB) to smoking cues
Number of subjects: 21
Study 32058247 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulatory assessment of attentional bias (AB) to alcohol cues
Number of subjects: 21
Study 32058247 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of smoking AB and alcohol AB
Number of subjects: 21
Study 32058247 — intervention group
Group type: EXPERIMENTAL
Intervention: Association of AB with craving
Number of subjects: 21
Study 34296383 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed SCP
Number of subjects: 378
Study 34296383 — intervention group
Group type: EXPERIMENTAL
Intervention: SCP delivered during an in‐person survivorship visit
Number of subjects: 378
Study 34296383 — intervention group
Group type: EXPERIMENTAL
Intervention: SCP delivered during an in‐person survivorship visit plus 6‐month follow‐up
Number of subjects: 378
Study 34296383 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 378
Study 34479632 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion-focused mindfulness therapy (EFMT) delivered via telehealth (Zoom)
Number of subjects: 48
Study 34479632 — intervention group
Group type: COMPARATOR
Intervention: Wait list control (no treatment)
Number of subjects: 48
Study 35711820 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg intramuscular nandrolone
Number of subjects: 23
Study 35711820 — intervention group
Group type: COMPARATOR
Intervention: Normal saline placebo
Number of subjects: 23
Study 32160888 — intervention group
Group type: EXPERIMENTAL
Intervention: Angioembolization after PCNL
Number of subjects: 53
Study 32160888 — intervention group
Group type: COMPARATOR
Intervention: No angioembolization after PCNL
Number of subjects: 53
Study 32160888 — intervention group
Group type: EXPERIMENTAL
Intervention: Puncture correctness
Number of subjects: 53
Study 36254494 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeting and Re‐aligning Agriculture to Improve Nutrition (TRAIN) programme
Number of subjects: 0
Study 36254494 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition counselling, agriculture extension, supervision, training, monitoring and evaluation, community events
Number of subjects: 0
Study 36254494 — intervention group
Group type: EXPERIMENTAL
Intervention: Personnel, travel, supplies
Number of subjects: 0
Study 32835958 — intervention group
Group type: EXPERIMENTAL
Intervention: Counterconditioning (imagery counterconditioning protocol)
Number of subjects: 0
Study 32835958 — intervention group
Group type: COMPARATOR
Intervention: No Counterconditioning (standard ExRP)
Number of subjects: 0
Study 34613339 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic treatment (fluoropyrimidine-based chemotherapy with bevacizumab)
Number of subjects: 196
Study 34613339 — intervention group
Group type: COMPARATOR
Intervention: Primary tumor resection (PTR) followed by systemic treatment (fluoropyrimidine-based chemotherapy with bevacizumab)
Number of subjects: 196
Study 36188617 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailin formulation (TLF) + Continuous low-dose antibiotic therapy (CLAT)
Number of subjects: 195
Study 36188617 — intervention group
Group type: COMPARATOR
Intervention: Continuous low-dose antibiotic therapy (CLAT)
Number of subjects: 195
Study 32936838 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyclonal sera from genotype B5- or C4-infected patients
Number of subjects: 23
Study 32936838 — intervention group
Group type: EXPERIMENTAL
Intervention: Human monoclonal antibodies (MAbs) derived from genotype B5 virus-infected individuals
Number of subjects: 23
Study 32936838 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutralizing antibodies targeting VP1 S241, VP3 E81, and VP2 D84 on genotype C1 viral capsid
Number of subjects: 23
Study 32936838 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutralizing antibodies in hSCARB2-transgenic mice model
Number of subjects: 23
Study 35242191 — intervention group
Group type: EXPERIMENTAL
Intervention: L‐PRF over ATBG around immediately inserted implants (test group)
Number of subjects: 26
Study 35242191 — intervention group
Group type: COMPARATOR
Intervention: Control group (without L‐PRF)
Number of subjects: 26
Study 33568038 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesitherapy combined with daily administration of Fortigel®, Vitamin C, sodium hyaluronate, manganese and copper (Group B)
Number of subjects: 60
Study 33568038 — intervention group
Group type: COMPARATOR
Intervention: Kinesitherapy alone (Group A)
Number of subjects: 60
Study 34101206 — intervention group
Group type: EXPERIMENTAL
Intervention: Low fluence Q switched ND:YAG 1064-nm laser (6 sessions)
Number of subjects: 50
Study 34101206 — intervention group
Group type: COMPARATOR
Intervention: Topical silymarin cream 1.4% (3-month treatment)
Number of subjects: 50
Study 32778175 — intervention group
Group type: EXPERIMENTAL
Intervention: D-ribose supplementation (15g in 200ml solution)
Number of subjects: 21
Study 32778175 — intervention group
Group type: EXPERIMENTAL
Intervention: D-ribose supplementation
Number of subjects: 21
Study 32778175 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sorbitol and β-cyclodextrin)
Number of subjects: 21
Study 34254731 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi intervention (1-hour class twice weekly for 16 weeks)
Number of subjects: 160
Study 36435003 — intervention group
Group type: EXPERIMENTAL
Intervention: Midwife-led weight management program
Number of subjects: 426
Study 36435003 — intervention group
Group type: COMPARATOR
Intervention: Conventional obstetrician-led antenatal care
Number of subjects: 426
Study 33432459 — intervention group
Group type: EXPERIMENTAL
Intervention: Salacia chinensis (SC; 500 mg)
Number of subjects: 21
Study 33432459 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 32546796 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised hospital-based moderate to high intensity group exercise intervention
Number of subjects: 153
Study 32546796 — intervention group
Group type: COMPARATOR
Intervention: Instructed home-based individual pedometer intervention
Number of subjects: 153
Study 32546796 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 153
Study 32546796 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive cardiorespiratory fitness responders
Number of subjects: 153
Study 35700052 — intervention group
Group type: EXPERIMENTAL
Intervention: Cash + Care (C+C)
Number of subjects: 5116
Study 35700052 — intervention group
Group type: COMPARATOR
Intervention: Care
Number of subjects: 5116
Study 33632647 — intervention group
Group type: EXPERIMENTAL
Intervention: Kids’ meals are the right size for children
Number of subjects: 2373
Study 33632647 — intervention group
Group type: EXPERIMENTAL
Intervention: Doctors recommend a 600 kcal per meal limit for kids
Number of subjects: 2373
Study 33632647 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 kcal per meal is a generally recommended limit for kids
Number of subjects: 2373
Study 33632647 — intervention group
Group type: COMPARATOR
Intervention: Nonfood control
Number of subjects: 2373
Study 33040778 — intervention group
Group type: EXPERIMENTAL
Intervention: Dengzhanshengmai capsules combined with butylphthalide softgels
Number of subjects: 123
Study 33040778 — intervention group
Group type: COMPARATOR
Intervention: Control group A (butylphthalide soft capsules)
Number of subjects: 123
Study 33040778 — intervention group
Group type: COMPARATOR
Intervention: Control group B (Dengzhanshengmai capsules)
Number of subjects: 123
Study 35954543 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentary workplace intervention
Number of subjects: 24
Study 34709582 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 5 mg
Number of subjects: 32
Study 34709582 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 50 mg
Number of subjects: 32
Study 34709582 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 1000 mg
Number of subjects: 32
Study 33852508 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing care with gliclazide
Number of subjects: 90
Study 33852508 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing care with pioglitazone hydrochloride
Number of subjects: 90
Study 33852508 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing care with sitagliptin
Number of subjects: 90
Study 33852508 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing care with exenatide
Number of subjects: 90
Study 33852508 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing care with liraglutide
Number of subjects: 90
Study 33852508 — intervention group
Group type: COMPARATOR
Intervention: Control group with gliclazide
Number of subjects: 90
Study 33852508 — intervention group
Group type: COMPARATOR
Intervention: Control group with pioglitazone hydrochloride
Number of subjects: 90
Study 33852508 — intervention group
Group type: COMPARATOR
Intervention: Control group with sitagliptin
Number of subjects: 90
Study 33852508 — intervention group
Group type: COMPARATOR
Intervention: Control group with exenatide
Number of subjects: 90
Study 33852508 — intervention group
Group type: COMPARATOR
Intervention: Control group with liraglutide
Number of subjects: 90
Study 36376930 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucocorticoid treatment
Number of subjects: 280
Study 36376930 — intervention group
Group type: EXPERIMENTAL
Intervention: HITAS score
Number of subjects: 280
Study 36074960 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Milch technique
Number of subjects: 126
Study 36074960 — intervention group
Group type: COMPARATOR
Intervention: Hippocratic method (Control)
Number of subjects: 126
Study 32746033 — intervention group
Group type: EXPERIMENTAL
Intervention: LASSO regression with extended feature-set including quadratic terms (LASSO_Q)
Number of subjects: 218
Study 32746033 — intervention group
Group type: COMPARATOR
Intervention: Standard formula (SF)
Number of subjects: 218
Study 32746033 — intervention group
Group type: COMPARATOR
Intervention: Literature methods (three ΔG-accounting variants)
Number of subjects: 218
Study 32746033 — intervention group
Group type: EXPERIMENTAL
Intervention: LASSO_Q
Number of subjects: 218
Study 32443179 — intervention group
Group type: EXPERIMENTAL
Intervention: Poll measuring respondent approval for Medicare For All (MFA) with the name and description
Number of subjects: 5051
Study 32443179 — intervention group
Group type: EXPERIMENTAL
Intervention: Poll measuring approval for Medicaid Buy-In (MBI) with the name and description
Number of subjects: 5051
Study 32443179 — intervention group
Group type: COMPARATOR
Intervention: Poll measuring approval for Medicare For All (MFA) with only a description
Number of subjects: 5051
Study 32443179 — intervention group
Group type: COMPARATOR
Intervention: Poll measuring approval for Medicaid Buy-In (MBI) with only a description
Number of subjects: 5051
Study 35084377 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 32005294 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated nutrition, health, water sanitation and hygiene, psychosocial care and support intervention package delivered during the pre and peri-conception period and/or during pregnancy and early childhood
Number of subjects: 13500
Study 32005294 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 13500
Study 35900386 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid (TXA) 500 mg/5 ml
Number of subjects: 26
Study 35900386 — intervention group
Group type: COMPARATOR
Intervention: Moffett’s solution (control)
Number of subjects: 26
Study 35900386 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 26
Study 33509935 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 exercise sessions on 5 consecutive days (5S)
Number of subjects: 26
Study 33509935 — intervention group
Group type: COMPARATOR
Intervention: 2 exercise sessions on 2 days (2S)
Number of subjects: 26
Study 32273589 — intervention group
Group type: EXPERIMENTAL
Intervention: Inoculation with Azospirillum brasilense and silicon (Si)
Number of subjects: 4
Study 32273589 — intervention group
Group type: COMPARATOR
Intervention: Inoculation with Azospirillum brasilense
Number of subjects: 4
Study 32273589 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicon (Si) use
Number of subjects: 4
Study 34269243 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal + pictorial postoperative care instructions (Group B)
Number of subjects: 39
Study 34269243 — intervention group
Group type: COMPARATOR
Intervention: Verbal postoperative care instructions (Group A)
Number of subjects: 39
Study 32268161 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile app follow-up
Number of subjects: 60
Study 32268161 — intervention group
Group type: COMPARATOR
Intervention: Conventional follow-up
Number of subjects: 60
Study 32270544 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 cl bottles
Number of subjects: 186
Study 32270544 — intervention group
Group type: COMPARATOR
Intervention: 50 cl bottles
Number of subjects: 186
Study 35217236 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin/metformin (sitaformin)
Number of subjects: 0
Study 35217236 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 0
Study 35217236 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 0
Study 35217236 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33091433 — intervention group
Group type: EXPERIMENTAL
Intervention: SYN023 (0.3 mg/kg) alone
Number of subjects: 32
Study 33091433 — intervention group
Group type: EXPERIMENTAL
Intervention: SYN023 (0.3 mg/kg) in combination with rabies vaccine
Number of subjects: 32
Study 33091433 — intervention group
Group type: EXPERIMENTAL
Intervention: SYN023 (0.3 mg/kg)
Number of subjects: 32
Study 33001673 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticonflict intervention
Number of subjects: 0
Study 33001673 — intervention group
Group type: COMPARATOR
Intervention: Standard methods
Number of subjects: 0
Study 34419285 — intervention group
Group type: EXPERIMENTAL
Intervention: Tivozanib 1.5 mg orally once daily for 21 days in a 28-day cycle
Number of subjects: 30
Study 34419285 — intervention group
Group type: EXPERIMENTAL
Intervention: Tivozanib
Number of subjects: 30
Study 32361963 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality breathing exercises with respiratory biofeedback
Number of subjects: 72
Study 32361963 — intervention group
Group type: COMPARATOR
Intervention: Breathing exercises without respiratory biofeedback
Number of subjects: 72
Study 34601705 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous tibial nerve stimulation
Number of subjects: 50
Study 34601705 — intervention group
Group type: COMPARATOR
Intervention: Sham therapy
Number of subjects: 50
Study 32213454 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral psychotherapy (individual and group therapy), mean duration: 64.5 days
Number of subjects: 80
Study 35271808 — intervention group
Group type: EXPERIMENTAL
Intervention: PRBC-LyoPlas
Number of subjects: 432
Study 35271808 — intervention group
Group type: COMPARATOR
Intervention: 0.9% sodium chloride
Number of subjects: 432
Study 34706654 — intervention group
Group type: EXPERIMENTAL
Intervention: Phantom exercises
Number of subjects: 24
Study 34706654 — intervention group
Group type: COMPARATOR
Intervention: Mirror therapy and conventional physical therapy
Number of subjects: 24
Study 32899926 — intervention group
Group type: EXPERIMENTAL
Intervention: Eyes closed condition in pwPD
Number of subjects: 15
Study 32899926 — intervention group
Group type: COMPARATOR
Intervention: Eyes closed condition in control group
Number of subjects: 15
Study 32899926 — intervention group
Group type: EXPERIMENTAL
Intervention: Eyes opened vs. eyes closed conditions in pwPD
Number of subjects: 15
Study 34476847 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep loss
Number of subjects: 15
Study 34476847 — intervention group
Group type: COMPARATOR
Intervention: 8.5-hr sleep window
Number of subjects: 15
Study 33843329 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D printed transfer trays
Number of subjects: 30
Study 33843329 — intervention group
Group type: COMPARATOR
Intervention: PVS transfer trays
Number of subjects: 30
Study 33485813 — intervention group
Group type: EXPERIMENTAL
Intervention: Home Visits (HVs) conducted by a pharmacist and pharmacy students
Number of subjects: 18
Study 33485813 — intervention group
Group type: COMPARATOR
Intervention: Office Visits (OVs) where patients brought their medications into the office for review
Number of subjects: 18
Study 33485813 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-HV survey results
Number of subjects: 18
Study 32546477 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced paramedic‐initiated stroke assessment pathway (PASTA pathway)
Number of subjects: 453
Study 34476616 — intervention group
Group type: EXPERIMENTAL
Intervention: AgNPs alone
Number of subjects: 59
Study 34476616 — intervention group
Group type: EXPERIMENTAL
Intervention: AgNPs and ICG activated with diode laser (AN/ICG/DL)
Number of subjects: 59
Study 34476616 — intervention group
Group type: EXPERIMENTAL
Intervention: AgNPs activated with 0.3 W Er: YAG laser (AN/PIPS)
Number of subjects: 59
Study 34476616 — intervention group
Group type: EXPERIMENTAL
Intervention: AgNPs activated with tapered gutta‐percha (AN/MDA)
Number of subjects: 59
Study 34476616 — intervention group
Group type: EXPERIMENTAL
Intervention: AgNPs activated with ultrasonic (AN/PUI)
Number of subjects: 59
Study 34476616 — intervention group
Group type: COMPARATOR
Intervention: 2.5% sodium hypochlorite (Control)
Number of subjects: 59
Study 34476616 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 59
Study 32469138 — intervention group
Group type: EXPERIMENTAL
Intervention: Influenza vaccination
Number of subjects: 1037
Study 34384000 — intervention group
Group type: EXPERIMENTAL
Intervention: Dutasteride-Tamsulosin 0.5 mg/0.4 mg capsule formulation (Dakart®)
Number of subjects: 0
Study 34384000 — intervention group
Group type: COMPARATOR
Intervention: Combodart® (reference drug)
Number of subjects: 0
Study 34710658 — intervention group
Group type: EXPERIMENTAL
Intervention: DPCP with multi‐concentration patch test
Number of subjects: 30
Study 34710658 — intervention group
Group type: COMPARATOR
Intervention: Standard protocol for immunotherapy
Number of subjects: 30
Study 32105334 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care + nature-based rehabilitation
Number of subjects: 101
Study 32105334 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 101
Study 35279970 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mL of 0.25% ropivacaine with 0.5 μg/kg (1 mL) dexmedetomidine (Group B)
Number of subjects: 60
Study 35279970 — intervention group
Group type: COMPARATOR
Intervention: 20 mL of 0.25% ropivacaine with 1 mL of normal saline (Group A)
Number of subjects: 60